EP3076969
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.12.2014EP published:
1.9.2021EP application number:
14812658.4
EPO information:
European Patent Register
Max expiry date:
2.12.2034
Title:
DOSAGE REGIMEN FOR AN ALPHA-ISOFORM SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
Timeline
Today
3.12.2014EP application
1.9.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
DI TOMASO, EmmanuelleAddress:
Cambridge, MA 02139, US
Name:
GERMA, Marie-CarolineAddress:
92506 Rueil-Malmaison Cedex, FR
Name:
MASSACESI, CristianAddress:
92506 Rueil-Malmaison, FR
Name:
FRITSCH, ChristineAddress:
4002 Basel, CH
Name:
SCHNELL, Christian ReneAddress:
4002 Basel, CH
Name:
TAVORATH, RanjanaAddress:
East Hanover, NJ 07936, US
Priority
Number:
13306679Date:
6.12.2013Country:
EP
Classification
Categories:
A61K 31/4439, A61P 35/00